These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 7478586)

  • 41. Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signaling through CD40 and interleukin-4 receptor: role for inhibition of an early response gene, Berg36.
    Ning ZQ; Norton JD; Li J; Murphy JJ
    Eur J Immunol; 1996 Oct; 26(10):2356-63. PubMed ID: 8898945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias.
    Alnemri ES; Fernandes TF; Haldar S; Croce CM; Litwack G
    Cancer Res; 1992 Jan; 52(2):491-5. PubMed ID: 1728422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effect of transforming growth factor beta 1 on the proliferation of human lymphoid and myeloid leukemia cells.
    Piacibello W; Severino A; Stacchini A; Aglietta M
    Haematologica; 1991; 76(6):460-6. PubMed ID: 1820982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transforming growth factor beta 1 induces apoptotic cell death in cultured human gastric carcinoma cells.
    Yanagihara K; Tsumuraya M
    Cancer Res; 1992 Jul; 52(14):4042-5. PubMed ID: 1319836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered regulation of protein disulfide isomerase in cells resistant to the growth-inhibitory effects of transforming growth factor beta 1.
    Sipes NJ; Miller DA; Bascom CC; Winkler JK; Matrisian LM; Moses HL
    Cell Growth Differ; 1990 May; 1(5):241-6. PubMed ID: 2085467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for c-myc in the signaling pathway for TGF-beta in well-differentiated human colon carcinoma cells.
    Mulder KM; Humphrey LE; Choi HG; Childress-Fields KE; Brattain MG
    J Cell Physiol; 1990 Dec; 145(3):501-7. PubMed ID: 2273056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antisense inhibition of c-myc expression reveals common and distinct mechanisms of growth inhibition by TGF beta and TNF alpha.
    Robinson-Benion C; Salhany KE; Hann SR; Holt JT
    J Cell Biochem; 1991 Feb; 45(2):188-95. PubMed ID: 2055946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent.
    Warner GL; Ludlow JW; Nelson DA; Gaur A; Scott DW
    Cell Growth Differ; 1992 Mar; 3(3):175-81. PubMed ID: 1633108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell cycle analysis of p26-BCL-2 protein levels in proliferating lymphoma and leukemia cell lines.
    Reed JC; Tanaka S; Cuddy M
    Cancer Res; 1992 May; 52(10):2802-5. PubMed ID: 1581893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Constitutive versus cell cycle regulation of c-myb mRNA expression correlates with developmental stages in murine B lymphoid tumors.
    Catron KM; Purkerson JM; Isakson PC; Bender TP
    J Immunol; 1992 Feb; 148(3):934-42. PubMed ID: 1730880
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
    Sharp NA; Luscombe MJ; Clemens MJ
    Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between DNA cross-links, cell cycle, and apoptosis in Burkitt's lymphoma cell lines differing in sensitivity to nitrogen mustard.
    O'Connor PM; Wassermann K; Sarang M; Magrath I; Bohr VA; Kohn KW
    Cancer Res; 1991 Dec; 51(24):6550-7. PubMed ID: 1742728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines.
    Inman GJ; Allday MJ
    J Gen Virol; 2000 Jun; 81(Pt 6):1567-78. PubMed ID: 10811940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage.
    Blomhoff HK; Smeland E; Mustafa AS; Godal T; Ohlsson R
    Eur J Immunol; 1987 Feb; 17(2):299-301. PubMed ID: 3030769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TGF beta inhibits Go/S-phase transition in primary fibroblasts. Loss of response to the antigrowth effect of TGF beta is observed after immortalization.
    Sorrentino V; Bandyopadhyay S
    Oncogene; 1989 May; 4(5):569-74. PubMed ID: 2498805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of LFA-1 surface antigen expression by activated H-ras oncogene in EBV-infected human B-lymphoblast cells.
    Endo K; Borer CH; Tsujimoto Y
    Oncogene; 1991 Aug; 6(8):1391-6. PubMed ID: 1653411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aphidicolin-induced proliferative arrest of murine mast cells: morphological and biochemical changes are not accompanied by alterations in cytokine gene induction.
    Costa JJ; Keffer JM; Goff JP; Metcalfe DD
    Immunology; 1992 Jul; 76(3):413-21. PubMed ID: 1382041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitivity to dexamethasone and absence of bcl-2 protein in Burkitt's lymphoma cell line (Black93) derived from a patient with acute tumor lysis syndrome: comparative study with other BL and non-BL lines.
    Tani A; Tatsumi E; Nakamura F; Kumagai S; Kosaka Y; Sano K; Nakamura H; Amakawa R; Ohno H
    Leukemia; 1996 Oct; 10(10):1592-603. PubMed ID: 8847894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. fgr proto-oncogene mRNA induced in B lymphocytes by Epstein-Barr virus infection.
    Cheah MS; Ley TJ; Tronick SR; Robbins KC
    Nature; 1986 Jan 16-22; 319(6050):238-40. PubMed ID: 3003578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minocycline is cytoprotective in human corneal endothelial cells and induces anti-apoptotic B-cell CLL/lymphoma 2 (Bcl-2) and X-linked inhibitor of apoptosis (XIAP).
    Kernt M; Hirneiss C; Neubauer AS; Kampik A
    Br J Ophthalmol; 2010 Jul; 94(7):940-6. PubMed ID: 20606027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.